Tumor progression locus 2 (Tpl2) is a serine/threonine kinase that promotes inflammatory cytokine production by activating the MEK/ERK pathway. Tpl2 has been shown to be important for eliciting the inflammatory properties of macrophages; however, there is relatively little known about the contribution of Tpl2 to neutrophil effector functions. This is an important consideration, as neutrophils provide the first line of defense against infection in the innate immune system. We found that Tpl2 is expressed in both human and murine neutrophils, suggesting a potential function for Tpl2 in this lineage. Despite significantly higher proportions of bone marrow (BM) neutrophils in Tpl2-deficient (Tpl2 2/2 ) mice compared with wild-type (WT) mice, Tpl2 2/2 mice have significantly reduced proportions of circulating neutrophils. Tpl2 2/2 neutrophils show impaired recruitment to thioglycollate, which was primarily a result of neutrophilextrinsic factors in the host. In response to infection, neutrophils secrete inflammatory cytokines and produce reactive oxygen species (ROS), which promote bacterial killing. Tpl2 ablation impaired neutrophil TNF secretion in response to LPS stimulation, superoxide generation in response to the chemotactic peptide fMLP, and killing of the extracellular bacterium, Citrobacter rodentium, despite normal bacterial phagocytosis. These results implicate Tpl2 in the regulation of multiple neutrophil antimicrobial pathways, including inflammatory cytokine secretion and oxidative burst. Furthermore, they indicate that Tpl2 functions early during infection to bolster neutrophil-mediated innate immunity against extracellular bacteria.
Introduction
Tpl2 (also known as MEK kinase 8, or MAP3K8) is a serinethreonine protein kinase originally described as an oncogene, as its C-terminal truncation promoted tumors in rodents [1] . Tpl2 is expressed in both innate and adaptive immune cells and in diverse tissues, including the spleen, thymus, liver, lung, and intestines [1] [2] [3] . Tpl2 promotes inflammation by inducing cytokines [4] [5] [6] [7] , chemokines [8, 9] , and other inflammatory mediators [10] . Many of the functions of Tpl2 have been attributed to its activation of the MEK/ERK pathway (reviewed in Gantke et al. [3] ), but Tpl2 also influences other cellular pathways as well, including p38, JNK, protein kinase B, and mammalian target of rapamycin, in a context-dependent manner [2, 11, 12] . In macrophages, Tpl2 is required for the processing and secretion of TNF [4, 13] . Initial characterization of Tpl2 2/2 mice identified major defects in the induction of proinflammatory cytokines, particularly TNF, by APCs that conveyed resistance to endotoxin-induced septic shock in Tpl2 2/2 mice [4] . Because it promotes TNF secretion, Tpl2 is being investigated as a therapeutic target for treating autoimmune diseases, especially those exacerbated by TNF, such as rheumatoid arthritis [14] [15] [16] . However, little is known about how Tpl2 regulates neutrophil functions. Neutrophils are the first cell type recruited to sites of inflammation from the circulation. It has been shown previously that Tpl2 2/2 mice treated with zymosan, acetaminophen, or caerulein show decreased neutrophil recruitment associated with peripheral inflammation [8, 17, 18] . However, reduced recruitment was attributed to impaired expression of inflammatory chemokines at the tissue sites, and the functionality of Tpl2 2/2 neutrophils was not investigated in these studies. Once in inflamed tissue, the primary function of neutrophils is the release of granules and phagocytosis of microbes and infected cells. Neutrophils kill and degrade microbes in the neutrophil phagolysosome through production of ROS by NADPH oxidase, RNS, and proteolytic enzymes, such as lysozyme and neutrophil elastase (reviewed in Amulic et al. [19] ). Overactivation of neutrophils can lead to damage of normal tissue through release of ROS, RNS, and enzymes. Downstream signaling through ERK assists in neutrophil development and differentiation from common progenitor cells [20] and in neutrophil antimicrobial functions [21, 22] . Because Tpl2 regulates ERK function in a cell type-and stimulus-specific manner [2] , we hypothesize that Tpl2 may contribute to neutrophil development and/or antimicrobial functions.
We first confirmed the expression of Tpl2 in neutrophils. In Tpl2 2/2 mice, we observed greater accumulation of neutrophils in the BM and reduced concentrations of circulating neutrophils. This difference correlated with reduced neutrophil recruitment in response to thioglycollate. However, Tpl2 2/2 neutrophils in the circulation expressed similar levels of the chemokine receptors and selectins CXCR2, CXCR4, CD44, and CD62L, and Tpl2 primarily regulated neutrophil recruitment in a cellextrinsic manner. Upon ex vivo stimulation, reduced TNF secretion, superoxide production, and bacterial killing were observed by Tpl2 2/2 neutrophils, as a result of cell-intrinsic functions of Tpl2. Combined, these data indicate a requirement for Tpl2 in neutrophil oxidative burst and bacterial killing that is compounded in a Tpl2 2/2 mouse that also experiences reduced neutrophil recruitment. These findings further support the use of Tpl2 inhibitors as an alternative therapeutic approach against autoimmune diseases exacerbated by TNF production but cautions that Tpl2 inhibitors may also predispose patients to bacterial infections that require neutrophil function for clearance.
MATERIALS AND METHODS

Mice
WT mice (C57BL/6) were obtained from The Jackson Laboratory (Bar Harbor, ME, USA), CD45. 
Human subjects
Peripheral blood collection from anonymous healthy donors has been approved by the Institutional Review Board of the UGA (UGA #2012-10769-06). Enrolled adult volunteers were nonpregnant and heavier than 110 pounds, without any infectious disease complication (based on self-report). All subjects provided informed consent. The studies were performed following the guidelines of the World Medical Association's Declaration of Helsinki.
Cell lines
Human airway epithelial cell lines A549 and NCI-H292 were obtained from ATCC (Manassas, VA, USA), and Cdk4/hTERT were kindly provided by Dr. John Minna at the University of Texas Southwestern Medical Center (Dallas, TX, USA) [23] . NCI-H292 cells were maintained in complete RPMI medium, as described [24] . The Cdk4/hTERT human bronchial epithelial cell line was cultured and differentiated as described [25] .
Primary cell isolation and cell sorting
Human neutrophil granulocytes were obtained from the peripheral blood of healthy volunteers as described [26] . In brief, RBCs were removed by Dextran sedimentation of the anticoagulant-treated blood, and neutrophils were separated using multistep Percoll gradient centrifugation. In mice, BM neutrophils were isolated from femurs and tibiae of naive mice or from peritoneal cells collected 4 h post-i. 
Flow cytometry and cell differentiation
Surface staining of murine neutrophils used the following anti-mouse mAb from eBioscience: CD16/CD32 (93), Gr-1 (RB6-8C5), CD11b (M1/70), CD44 (IM7), CD62L (MEL-14), CD45.1 (A20), and CD45.2 (104); or from BioLegend (San Diego, CA, USA): CXCR2 (SA044G4) and CXCR4 (L276F12). Samples were run on a BD LSR II flow cytometer (BD Biosciences, San Jose, CA, USA) and analyzed using FlowJo software (Tree Star, Ashland, OR, USA). Blood was collected by tail bleed or terminal cardiac puncture into microvette tubes containing EDTA (Starstedt, Nümbrecht, Germany). Proportions and total WBCs, reported as cells per microliter, were measured using a HemaTrue Veterinary Hematology Analyzer (Heska/Cuattro, Loveland, CO, USA).
Western blotting
Cells were lysed in protein lysis buffer [dH 2 O; 100 mM HEPES, pH 7.5; 20% glycerol; 2% Triton X-100; 3 mM MgCl 2 ; 2 mM EDTA; 1 ng/ml leupeptin, aprotinin, and pepstatin; 1 nM PMSF; and protease inhibitor tablet (Roche, Basel, Switzerland)]. Protein concentration was measured using a bicinchoninic acid protein assay (Thermo Fisher Scientific). Membrane and cytoplasm fractions were isolated using a Cell Fractionation Kit (Cell Signaling Technology, Danvers, MA, USA), according to the manufacturer's guidelines. Total protein was separated on a 4-12% Bis-Tris gel (Thermo Fisher Scientific) under reducing conditions and transferred to polyvinylidene difluoride membranes using the iBlot gel transfer system (Thermo Fisher Scientific). Membranes were probed with antibodies for Tpl2, p47, and b-actin (Santa Cruz Biotechnology, Dallas, TX, USA) and GAPDH (GeneTex, Irvine, CA, USA), followed by HRPlabeled secondary antibodies. Protein bands were visualized by ECL reagent (Lumigen, Southfield, MI, USA), and band density was measured using ImageJ software (U.S. National Institutes of Health, Bethesda, MD, USA).
RNA isolation and RT-PCR
RNA was isolated from cells using the E.Z.N.A RNA extraction kit (Omega Bio-tek, Norcross, GA, USA) and converted to cDNA by the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific). Relative expression levels of Tpl2 were measured using the SensiFAST Probe Hi-ROX kit (Bioline, Taunton, MA, USA) and predesigned TaqMan probe and primer sets (Thermo Fisher Scientific). Samples were run on a StepOnePlus qPCR machine (Thermo Fisher Scientific). Results given are relative to neutrophils (mouse samples) or Cdk4/hTERT (human samples) and an actin housekeeping gene using the comparative threshold method. 
Adoptive transfer and mixed BM chimeras
BM extracellular fluid and cytokine measurements
Holes were punched in the bottom of a 0.5 ml tube and placed into a 2 ml tube. Femurs were collected from mice, cut in half, and put open-side down into the 0.5 ml tube with 200 ml PBS. Tubes were centrifuged for 20 s at 3,300 relative centrifugal force, and supernatants were collected into new tubes. Each data point represents the average of both femurs. BM extracellular fluid concentrations of SDF-1 and serum concentrations of G-CSF were measured by ELISA (RayBiotech, Norcross, GA, USA), according to the manufacturer's guidelines. A total of 250,000 neutrophils/well were allowed to adhere to 96-well plates. Cells were stimulated for 24 h with 100 ng/ml LPS at 37°C in media containing HBSS, 100 mM HEPES, 5 mM glucose, and 1% mouse serum. TNF concentrations were measured by ELISA (eBioscience), according to the manufacturer's guidelines.
C. rodentium C. rodentium strain DBS100 (ATCC 5159) was purchased from ATCC. Gad Frankel at Imperial College (London, United Kingdom) kindly provided the luminescent C. rodentium strain (ICC180) [27] . Lynn Bry at Brigham and Women's Hospital (Boston, MA, USA) kindly provided the GFP-C. rodentium [28] . C. rodentium was grown in LB medium (containing 100 mg/ml piperacillin for GFP-C. rodentium). Bacteria were opsonized with 100% murine serum for 15 min at 37°C. The MOI was confirmed by retrospective plating on LB agar plates 6 100 mg/ml piperacillin.
Measurement of superoxide production
Superoxide production in adherent neutrophils was measured by Diogenes superoxide detection chemiluminescence kit (National Diagnostics, Atlanta, GA, USA). A total of 50,000 neutrophils/well were allowed to adhere to 96-well white plates (15 min, 37°C, HBSS). Cells were stimulated by addition of 100 nM fMLP, 1 mM PMA, and C. rodentium ATCC 51459 (MOI 2, 10, and 20) or were left unstimulated. Chemiluminescence was measured by a Varioskan Flash luminometer (Thermo Fisher Scientific) for 30 min.
Bacterial adhesion, phagocytosis, and killing
Bacterial killing was calculated by combining 100,000 BM neutrophils with increasing concentrations of luminescent C. rodentium (ICC180). Luminescence was measured by a Varioskan Flash luminometer (Thermo Fisher Scientific) for 3 h (37°C, HBSS, 100 mM HEPES, 5 mM glucose, and 1% mouse serum). Bacterial adhesion and phagocytosis were calculated by combining 150,000 peritoneal neutrophils with increasing concentrations of GFP-C. rodentium for 0, 30, and 60 min (4°C or 37°C, HBSS, 100 mM HEPES, 5 mM glucose, and 1% mouse serum). The percent of GFP-positive neutrophils was measured by flow cytometry.
Statistics P values were derived by two-tailed paired or unpaired Student's t test using Prism software (GraphPad Software, La Jolla, CA, USA), unless otherwise indicated. Differences were considered statistically significant if P # 0.05.
RESULTS
Tpl2 is expressed in mouse and human neutrophils
The importance of Tpl2 in innate immune cells, such as macrophages and dendritic cells, and adaptive immune cells, such as CD4 T cells, has been studied extensively. However, how Tpl2 influences neutrophil function has yet to be investigated. First, we evaluated the expression of Tpl2 in neutrophils relative to other innate or adaptive immune cells. Tpl2 is expressed as 2 distinct isoforms of 52 and 58 kDa in both innate and adaptive immune cells [29] . In murine cells, Tpl2 is more highly expressed in neutrophils compared with naive CD4 T cells but not as highly expressed as in naive peritoneal macrophages, B cells, or NK cells (Fig. 1A and B) . Notably, the p52 isoform appears to be the dominant isoform expressed in neutrophils, compared with other cell types analyzed that equally express both isoforms (Fig. 1A ). Tpl2 has previously been shown to influence cytokine secretion of IL-6 and IL-8 (CXCL8) in the human bronchial airway epithelial cell line BEAS-2B [30] . Accordingly, Tpl2 is expressed in the human lung epithelial cell lines Cdk4/hTERT, NCI-H292, and A549 (Fig. 1C ), but Tpl2 expression is even higher in primary human neutrophils (Fig. 1C) .
These results indicate that Tpl2 is expressed in neutrophils at physiologically relevant levels, where it may contribute to neutrophil antimicrobial functions.
Tpl2
2/2 mice have greater accumulation of neutrophils in the BM Neutrophil development from progenitors proceeds through several stages in the BM before being released into the circulation [31] . To investigate whether Tpl2 contributes to neutrophil development in the BM, whole BM from naive mice was evaluated. Tpl2 2/2 mice had higher proportions of granulocytes (as determined by FSC and SSC), Gr-1 hi neutrophils, and Gr-1 int monocytes ( Fig. 2A and B) . One factor that has been shown to regulate neutrophil proportions in the BM is the microbiota [32] . However, Tpl2 2/2 mice had similarly elevated proportions of BM granulocytes, neutrophils, and monocytes compared with their WT littermates (Fig. 2C) , confirming a role for Tpl2 in the accumulation of BM granulocytes independent of the microbiota. Once neutrophils mature in the BM, they are released into the circulation. Despite elevated proportions of neutrophils in the BM, Tpl2 2/2 mice have reduced proportions of neutrophils in the blood, with a commensurate increase in the proportions of lymphocytes (Fig. 2D) . However, Tpl2 only directly impacts circulating neutrophil concentrations (Fig. 2E) , which in turn, indirectly influences lymphocyte proportions. Additionally, despite higher proportions of Gr-1 int monocytes in the BM of Tpl2 2/2 mice (Fig. 2C) , Tpl2 does not impact relative proportions or concentrations of circulating monocytes ( Fig. 2D and E) . Therefore, we focused our attention on the importance of Tpl2 in neutrophil function, and to prevent underlying differences in how microbiota may influence experimental outcome, all remaining experiments were conducted using WT and Tpl2 2/2 mice bred from heterozygous matings.
Tpl2 does not impact known regulators of neutrophil egress
In Tpl2 2/2 mice, we observed greater accumulation of neutrophils in the BM and reduced circulating neutrophils, indicating defects in neutrophil egress from the BM. Tpl2 has previously been shown to regulate chemokine receptor expression on macrophages, including CCR1 [33] . As CXCR4 and its ligand CXCL12 (SDF-1) are thought to regulate neutrophil egress negatively from the BM into the circulation [34, 35] , we hypothesized that CXCR4 expression on the surface of Tpl2 2/2 BM neutrophils and SDF-1 concentrations in the BM extracellular fluid may be altered. However, WT and Tpl2 2/2 BM neutrophils expressed similar levels of CXCR4 (Fig. 3A) , and similar concentrations of SDF-1 were isolated from the BM extracellular fluid (Fig. 3C) . Alternatively, production of G-CSF is thought to enhance neutrophil mobilization from the BM into the circulation [36] ; however, naive Tpl2 2/2 mice had similar concentrations of G-CSF in their sera (Fig. 3D ). These data suggest that Tpl2 regulates neutrophil egress from the BM by a currently unknown mechanism. WT and Tpl2 2/2 mice from homozygous matings or (C) from WT and Tpl2 2/2 littermates derived from heterozygous matings. Whole BM isolates were stained for Gr-1. Cells were gated on granulocytes, Gr-1 + neutrophils, and Gr-1 int monocytes; n $ 5. Blood was collected from littermates and analyzed for (D) proportions and (E) concentration of WBCs. Results are shown as a (D) proportion of all WBCs and (E) cells per microliter; n = 6. Connecting lines represent (B) age-and sex-matched mice from homozygous matings or (C-E) littermates that were analyzed on the same day. Lymph, lymphocytes; monos, monocytes. *P , 0.05, **P , 0.005 using paired Student's t test.
Neutrophil recruitment is impaired in Tpl2
2/2 mice as a result of a neutrophil-extrinsic defect Tpl2 has been shown to be required for neutrophil recruitment in response to treatment with zymosan [8] , acetaminophen [17] , and caerulein [18] , as well as during myelin oligodendrocyte glycoprotein -induced experimental autoimmune encephalomyelitis [11] . Decreased recruitment was attributed to reduced chemotactic factors generated at the site of inflammation in Tpl2 2/2 mice [8, 11, 17, 18] . Consistent with these findings, 3%
thioglycollate, which elicits a sterile inflammatory response, recruited 10-20% less neutrophils into the peritoneal cavity of Tpl2 2/2 mice compared with WT mice (Fig. 4A) . These results confirm the importance of Tpl2 in recruitment of neutrophils in the host. However, it is still unclear whether Tpl2 influences neutrophil recruitment in a neutrophil-intrinsic manner.
To determine the role of Tpl2 in neutrophil recruitment, two models were used to measure the cell-intrinsic role of Tpl2 during neutrophil recruitment in a WT host. In the first model, BM neutrophils were isolated from congenic CD45.1 + C57BL/6 and CD45.2 + Tpl2 2/2 mice, combined at a 1:1 ratio, and labeled with CFSE. Neutrophils were injected i.v. into WT (C57BL/6) mice, and the recipients were treated immediately with 1 ml of 3% thioglycollate i.p. Four hours post-treatment, mice were euthanized, and peritoneal cells were collected. Similar proportions of both CD45.1 + WT and CD45.1 -Tpl2 2/2 neutrophils were recruited into the peritoneal cavity (Fig. 4B) . Unimpaired BM neutrophils, isolated by positive selection, were stained with CFSE and combined at a 1:1 ratio, and 2 3 10 6 cells were injected i.v. into WT mice, followed by 1 ml 3% thioglycollate i.p. Four hours later, peritoneal exudate cells (PEC) were stained for Gr-1 and CD45.1. A representative plot of peritoneal exudate cells shows the gating strategy; n = 3. Results shown are representative of 2 independent experiments. (C) Mixed BM chimeras were injected with 1 ml 3% thioglycollate i.p. Peritoneal cells were collected 4 h later and stained for Gr-1, CD45.1, and CD45.2. A representative plot of peritoneal exudate cells shows the gating strategy; n = 4. Results shown are representative of 2 independent experiments. Error bars represent means 6 SEM. *P , 0.05, **P , 0.005, ***P , 0.001 using paired Student's t test. recruitment of Tpl2 2/2 neutrophils in the circulation correlated with normal levels of neutrophil chemokine receptors CXCR2 and CXCR4 [35, [37] [38] [39] , E-selectin CD44 [40] , and L-selectin CD62L (Fig. 3B) . In the second model, mixed BM chimeras were generated and treated with 3% thioglycollate. Eight weeks posttransfer, CD45.1/CD45.2 heterozygous recipient mice contained an ;1:1 (WT CD45.1 + :Tpl2 2/2 CD45.2 + ) neutrophil ratio in the blood (Fig. 4C) . Contrary to expectations, after treatment with 3% thioglycollate, both the blood and peritoneum unexpectedly showed elevated proportions of Tpl2 2/2 neutrophils compared with WT CD45.1 + neutrophils (Fig. 4C) . These 2 models have confirmed that recruitment is not impaired in Tpl2 2/2 neutrophils. Furthermore, these results indicate that Tpl2 predominately regulates neutrophil recruitment via a neutrophil-extrinsic defect, such as through reduced production of inflammatory chemokines, as reported previously [8, 11, 17, 18] , as neutrophilextrinsic functions of Tpl2 define the recruitment defect observed in the complete knockout model (Fig. 4A ).
Tpl2 promotes TNF secretion, respiratory burst, and bacterial killing
Once in an inflamed tissue, recruited neutrophils produce inflammatory cytokines, phagocytose microbes, generate superoxide, and form NETs to control infection. To determine how Tpl2 influences neutrophil antimicrobial functions, WT and Tpl2 2/2 neutrophils were stimulated ex vivo with the chemotactic peptide fMLP, LPS, PMA, or C. rodentium. Following stimulation with LPS, Tpl2 2/2 neutrophils secreted significantly less TNF compared with WT neutrophils (Fig. 5) . fMLP induced significant superoxide production in WT neutrophils, which was diminished in Tpl2 2/2 neutrophils ( Fig. 6A and B) . Defects in Membrane (M) and cytoplasm (C) fractions were probed for p47, and the ratio of membrane-tocytoplasm p47 density was calculated; n = 3. Error bars represent means 6 SEM. *P , 0.05 using twoway ANOVA.
superoxide generation by Tpl2 2/2 neutrophils, in response to fMLP, are consistent with defects in superoxide generation that we observed previously in Tpl2 2/2 macrophages in response to TLR ligands [41] . However, Tpl2 2/2 neutrophils are capable of producing superoxide in response to both C. rodentium and PMA stimulation ( Fig. 6A-C) , indicating a stimulus-specific defect in superoxide production by Tpl2 2/2 neutrophils.
Superoxide is generated through activation and formation of the NADPH oxidase complex, which is composed of 5 subunits: 2 membrane-bound subunits (p22 phox and gp91 phox ) and 3 cytoplasmic subunits (p40 phox , p47 phox , and p67 phox ) [42] . Upon activation, the 3 cytoplasmic subunits are recruited to the cell membrane, generating the active NADPH oxidase and allowing for production of superoxide [42] . We hypothesized that defects in superoxide production in response to fMLP by Tpl2 2/2 neutrophils are a result of defects in the NADPH oxidase. Indeed, impaired superoxide production by Tpl2 2/2 neutrophils in response to fMLP correlated with reduced recruitment of p47 from the cytoplasm to the membrane ( Fig. 6D and E) . Recruitment of p47 from the cytoplasm to the membrane in response to PMA was not impaired by Tpl2 2/2 neutrophils ( Fig. 6D and E) . Despite similar production of superoxide in response to C. rodentium, we hypothesized that Tpl2 2/2 neutrophils would be impaired in bacterial killing. C. rodentium is a nonmotile gramnegative rod that is a natural mouse and gerbil pathogen [43, 44] and is capable of being killed by murine neutrophils in vitro [45, 46] . WT or Tpl2 2/2 neutrophils were incubated with a luminescent strain of C. rodentium at a low dose of infection (MOI 1, 2, and 5), and bacterial persistence was monitored .3 h. Tpl2 2/2 neutrophils were less capable of killing C. rodentium compared with WT neutrophils, and all neutrophils were overwhelmed at the highest MOI ( Fig. 7A and B) . As Tpl2 has been shown to be required for FcgR-induced phagocytosis in macrophages [47] , impaired bacterial killing by Tpl2 2/2 neutrophils could be a result of impaired phagocytosis. However, Tpl2 2/2 neutrophils were equally capable of adhering to and phagocytosing high-and low-dose C. rodentium (Fig. 7C ). These data indicate basal defects in the ability of Tpl2 2/2 neutrophils to kill bacteria, despite similar bacterial phagocytosis (Fig. 7C ), superoxide production (Fig. 6E) , and expression of the activation marker CD11b (Fig. 3A and B) . Therefore, Tpl2 may instead impact additional killing mechanisms, such as degranulation and NETosis, leading to reduced bacterial killing by Tpl2 superoxide production, and cytokine secretion. Signaling through FcgR has been shown to activate Tpl2 and ERK in macrophages, allowing for secretion of TNF, IL-6, and IL-10 and for phagocytosis, all of which are reduced by Tpl2 inhibition [47] . Similar to macrophages, Tpl2 2/2 neutrophils showed impaired TNF secretion in response to LPS; however, Tpl2 2/2 neutrophils were equally capable of phagocytosis, further indicating cell type-specific responses by Tpl2. Superoxide production is a major component of neutrophil antimicrobial functions; however, this defect is stimulus specific to fMLP and can be overcome in response to C. rodentium or PMA by Tpl2 2/2 neutrophils. fMLP is known to activate the MEK/ERK signaling pathway leading to downstream superoxide production [53] , whereas PMA instead uses the protein kinase C signaling pathway [54] . The observed impairment in fMLP-induced oxidative burst is consistent with impaired formation of the NADPH oxidase complex and the known role for Tpl2 in activation of the MEK/ ERK pathway (reviewed in Gantke et al. [3] ). As a result of the speed at which the NADPH oxidase complex is formed in response to stimuli or mechanical stimulation, recruitment of the p47 subunit to the membrane in unstimulated neutrophils may be a result of activation during cell isolation.
The main goal of neutrophil antimicrobial functions is to promote an inflammatory environment and kill microbes. It has previously been shown that murine neutrophils are capable of killing the bacterial pathogen C. rodentium in vitro [45, 46] . In the current study, Tpl2 2/2 neutrophils were significantly impaired in their antimicrobial functions. These data implicate Tpl2 in bacterial killing in vitro, but neutrophil-mediated killing is a multistep process (reviewed in Kolaczkowska and Kubes [55] ) that includes phagocytosis, degranulation, respiratory burst, and release of NETs. As Tpl2 was not required for phagocytosis or superoxide production in response to C. rodentium, a combination of possible defects in additional killing mechanisms, such as degranulation and NETosis, likely underlies the reduced antimicrobial activity of Tpl2 2/2 neutrophils.
Overall, our findings underscore the importance of Tpl2 in driving innate immune cell inflammatory and antimicrobial properties. These findings further support the use of Tpl2 inhibitors as an alternative therapeutic approach against rheumatoid arthritis to combat overproduction of TNF [14] [15] [16] , as well as limit neutrophil recruitment. Besides being used as an infectious model for inflammatory bowel disease [56] , C. rodentium is also a model for intestinal bacterial pathogens that cause attaching and effacing lesions, similar to Escherichia coli infection [57, 58] . Therefore, whereas inhibition of Tpl2 may benefit patients who suffer from autoimmune diseases potentiated by inflammatory neutrophils, Tpl2 inhibitors taken chronically may also predispose patients to commensal bacterial infections that require neutrophil function for clearance. AUTHORSHIP N.V.A. designed the study, performed experiments, and wrote the manuscript. X.L. performed experiments in Fig. 5 . J.E. performed experiments in Figs. 1, 2, and 4 . B.R. and W.T.W. designed the study and wrote the manuscript.
